“The future is bright for neurohospitalists,” Dr. Freeman says.
Richard Quinn is a freelance writer based in New Jersey.
Related Articles
The cogPOISE-3 Trial: No Changes in Neurocognitive Outcomes Associated with Perioperative Hypotension Avoidance Versus Hypertension Avoidance
August 18, 2011
CLINICAL QUESTION: Does perioperative hypotension avoidance versus hypertension avoidance carry an increased risk of postoperative delirium or cognitive decline? BACKGROUND: There is concern that...
Pediatric Catatonia’s Medical Turn: Increasing Incidence and Intensifying Treatment
August 18, 2011
CLINICAL QUESTION: Has the incidence, etiology, evaluation, and management of pediatric catatonia changed over time, especially following the COVID-19 pandemic? BACKGROUND: Pediatric catatonia is a...
New Picture Stimuli for the NIHSS Validated
August 18, 2011
CLINICAL QUESTION: Does an updated National Institutes of Health Stroke Scale (NIHSS) language assessment tool perform well in a sample of diverse, neurologically unimpaired English-speaking...
Apixaban Versus Aspirin for Subclinical AF: Stroke Prevention and Bleeding Risk
August 18, 2011
CLINICAL QUESTION: Does apixaban reduce the risk of stroke or systemic embolism compared to aspirin in patients with subclinical atrial fibrillation and elevated stroke risk? BACKGROUND: Subclinical...